Robinson Bradshaw

Author: Bench to Market Contributor

Is an IPO the Right Thing for Your Company?

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by David W. Dabbs, Robinson, Bradshaw Hinson, P.A. You just spent the last five years of your life working virtually 24/7/365 to build your company into one of the most respected firms in its field. Three years ago you barely could […]

The Benefits and Limits of Non-Disclosure Agreements

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by Matthew S. Churchill, Robinson, Bradshaw Hinson, P.A. The last few articles in the Bench to Market series discussed capital raises and licensing-out arrangements that facilitate an entrepreneur’s commercialization of a new product or process. To obtain capital or a licensing […]

Raising Private Capital

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by Mark O. Henry, Robinson, Bradshaw & Hinson, P.A. Last week in the Bench to Market series, we discussed the license-out business model as an alternative to raising capital for the commercialization process. Because the business idea is “your baby,” however, […]

The License-Out as a Business Model

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by Steve Newmark, Robinson, Bradshaw & Hinson, P.A. The drive to create something new and useful is an almost universal trait of entrepreneurs. This passion, however, is not always accompanied by the same enthusiasm for managing the more mundane tasks of […]

What’s the Deal: Establishing the Ownership, Management, and Other Key Terms of the Business

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by David Miller, Robinson, Bradshaw & Hinson, P.A. We discussed earlier in the Bench to Market series the selection and formation of the legal entity that will own the technology and carry on the business of the founders. In connection with […]

Starting Out with Government Funding: SBIR and STTR Grants

This commentary in the Genomics Law Report’s ongoing series Bench to Market is contributed by Jon Jordan, Robinson, Bradshaw & Hinson, P.A. You’ve spent months or even years researching and believe you are on the brink of a major breakthrough. Your quest to develop a marketable product or technology is at a crossroads and, like […]